Synthesis and characterization of UPPE-PLGA-rhBMP2 scaffolds for bone regeneration

Abstract

A novel unsaturated polyphosphoester (UPPE) was devised in our previous research, which is a kind of promising scaffold for improving bone regeneration. However, the polymerization process of UPPE scaffolds was unfavorable, which may adversely affect the bioactivity of osteoinductive molecules added if necessary, such as recombinant human bone morphogenetic protein-2 (rhBMP2). The purpose of this study was to build a kind of optimal scaffold named UPPE-PLGA-rhBMP2 (UPB) and to investigate the bioactivity of rhBMP2 in this scaffold. Furthermore, the cytotoxicity and biocompatibility of UPB scaffold was assessed in vitro. A W1/O/W2 method was used to fabricate PLGA-rhBMP2 microspheres, and then the microspheres were added to UPPE for synthesizing UPB scaffold. The morphological characters of PLGA-rhBMP2 microspheres and UPB scaffolds were observed under the scanning electron microscopy and laser scanning confocal microscopy. The cumulative release of UPB scaffolds was detected by using ELISA. The cytotoxicity and biocompatibility of UPB scaffolds were evaluated through examining the adsorption and apoptosis of bone marrow stromal cells (bMSCs) seeded on the surface of UPB scaffolds. The bioactivity of rhBMP2 in UPB scaffolds was assessed through measuring the alkaline phosphates (ALP) activity in bMSCs seeded. The results showed that UPB scaffolds sequentially exhibited burst and sustained release of rhBMP2. The cytotoxicity was greatly reduced when the scaffolds were immersed in buffer solution for 2 h. bMSCs attached and grew on the surface of soaked UPB scaffolds, exerting well biocompatibility. The ALP activity of bMSCs seeded was significantly enhanced, indicating that the bioactivity of rhBMP2 remained and still took effect after the unfavorable polymerization process of scaffolds. It was concluded that UPB scaffolds have low cytotoxicity, good biocompatibility and preserve bioactivity of rhBMP2. UPB scaffolds are promising in improving bone regeneration.

Keywords

poly (lactic-co-glycolic acid) microspheres / bone morphogenetic protein-2 / unsaturated polyphosphoester / bone regeneration

References

[1] JanickiP., SchmidmaierG.. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury, 2011, 42(Supplement2): S77-S81

[2] HolzwarthJ.M., MaP.X.. Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials, 2011, 32(36): 9622-9629

[3] ButscherA., BohnerM., HofmannS., et al.. Structural and material approaches to bone tissue engineering in powder-based three-dimensional printing. Acta Biomaterialia, 2011, 7(3): 907-920

[4] RezwanK., ChenQ.Z., BlakerJ.J., et al.. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials, 2006, 27(18): 3413-3431

[5] TianH., TangZ., ZhuangX., et al.. Biodegradable synthetic polymers: Preparation, functionalization and biomedical application. Prog Polym Sci, 2012, 37(2): 237-280

[6] NavarroM., MichiardiA., CastañoO., et al.. Biomaterials in orthopaedics. J R Soc Interface, 2008, 5(27): 1137-1158

[7] PuppiD., ChielliniF., PirasA.M., et al.. Polymeric materials for bone and cartilage repair. Prog Polym Sci, 2010, 35(4): 403-440

[8] QiuJ., LiuC., HuF., et al.. Synthesis of unsaturated polyphosphoester as a potential injectable tissue engineering scaffold materials. J Appl Polym Sci, 2006, 102(4): 3095-3101

[9] LiB., YoshiiT., HafemanA.E., et al.. The effects of rhBMP-2 released from biodegradable polyurethane/ microsphere composite scaffolds on new bone formation in rat femora. Biomaterials, 2009, 30(35): 6768-6779

[10] ChaubalM.V., SuG., SpicerE., et al.. In vitro and in vivo degradation studies of a novel linear copolymer of lactide and ethylphosphate. J Biomater Sci Polym Ed, 2003, 14(1): 45-61

[11] WangD., WilliamsC.G., LiQ., et al.. Synthesis and characterization of a novel degradable phosphate-containing hydrogel. Biomaterials, 2003, 24(22): 3969-3980

[12] ZhaoZ., WangJ., MaoH.Q., et al.. Polyphosphoesters in drug and gene delivery. Adv Drug Deliv Rev, 2003, 55(4): 483-499

[13] MistryA.S., MikosA.G., JansenJ.A.. Degradation and biocompatibility of a poly(propylene fumarate)-based/ alumoxane nanocomposite for bone tissue engineering. J Biomed Mater Res Part A, 2007, 83A(4): 940-953

[14] KikuchiM., KoyamaY., TakakudaK., et al.. In vitro change in mechanical strength of β-tricalcium phosphate/ copolymerized poly-L-lactide composites and their application for guided bone regeneration. J Biomed Mater Res, 2002, 62(2): 265-272

[15] ChenD., ZhaoM., MundyG.. Bone morphogenetic proteins. Growth Factors, 2004, 22(4): 233-241

[16] WongC., InmanE., SpaetheR., et al.. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost, 2003, 89(3): 573-582

[17] WuG., HunzikerE.B., ZhengY., et al.. Functionalization of deproteinized bovine bone with a coating-incorporated depot of BMP-2 renders the material efficiently osteoinductive and suppresses foreign-body reactivity. Bone, 2011, 49(6): 1323-1330

[18] YilgorP., TuzlakogluK., ReisR.L.. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials, 2009, 30(21): 3551-3559

[19] LeeS., ShinH.. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliver Rev, 2007, 59(4–5): 339-359

[20] RatanavarapornJ., FuruyaH., KoharaH., et al.. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials, 2011, 32(11): 2797-2811

[21] LuoT., ZhangW., ShiB., et al.. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery. Clin Oral Implants Res, 2012, 23(4): 467-473

[22] ManakaT., SuzukiA., TakayamaK., et al.. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials, 2011, 32(36): 9642-9648

[23] JeonO., KangS., LimH., et al.. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials, 2006, 27(8): 1598-1607

[24] WinnS.R., UludagH., HollingerJ.O.. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliver Rev, 1998, 31(3): 303-318

[25] BoerckelJ.D., KolambkarY.M., DupontK.M., et al.. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials, 2011, 32(22): 5241-5251

[26] LeeJ.W., KangK.S., LeeS.H., et al.. Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres. Biomaterials, 2011, 32(3): 744-752

[27] ZhangZ., FengX., MaoJ., et al.. In vitro cytotoxicity of a novel injectable and biodegradable alveolar bone substitute. Biochem Bioph Res Co, 2009, 379(2): 557-561

[28] KempenD.H.R., LuL., KimC., et al.. Controlled drug release from a novel injectable biodegradable microsphere/ scaffold composite based on poly(propylene fumarate). J Biomed Mater Res Part A, 2006, 77A(1): 103-111

[29] KempenD.H., KruytM.C., LuL., et al.. Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly(propylene fumarate) composite. Tissue Eng Part A, 2009, 15(3): 587-594

[30] LiQ., WangJ., ShahaniS., et al.. Biodegradable and photocrosslinkable polyphosphoester hydrogel. Biomaterials, 2006, 27(7): 1027-1034

[31] BerklandC., KipperM.J., NarasimhanB., et al.. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release, 2004, 94(1): 129-141

[32] HanB., WangH., LiuH., et al.. Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies. Int J Pharm, 2010, 398(1–2): 130-136

[33] SongX., ZhaoY., WuW., et al.. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm, 2008, 350(1–2): 320-329

[34] DawsonJ.I., OreffoR.O.C.. Bridging the regeneration gap: Stem cells, biomaterials and clinical translation in bone tissue engineering. Arch Biochem Biophys, 2008, 473(2): 124-131

[35] DietmarW.H.. Scaffolds in tissue engineering bone and cartilage. Biomaterials, 2000, 21(24): 2529-2543

[36] CaoH., KuboyamaN.. A biodegradable porous composite scaffold of PGA/β-TCP for bone tissue engineering. Bone, 2010, 46(2): 386-395

[37] SeehermanH., LiR., BouxseinM., et al.. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am, 2006, 88(1): 144-160

[38] KimS.S., GwakS.J., KimB.S.. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/ hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res A, 2008, 87(1): 245-253

[39] SunJ., DaiZ., ZhaoY., et al.. In vitro effect of oligo-hydroxyalkanoates on the growth of mouse fibroblast cell line L929. Biomaterials, 2007, 28(27): 3896-3903

[40] SkotakM., LeonovA., LarsenG., et al.. Biocompatible and biodegradable ultrafine fibrillar scaffold materials for tissue engineering by facile grafting of L-lactide onto chitosan. Biomacromolecules, 2008, 9(7): 1902-1908

[41] Paillard-GiteauA., TranV.T., ThomasO., et al.. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique. Eur J Pharm Biopharm, 2010, 75(2): 128-136

[42] SongI., KimB.S., KimC.S., et al.. Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells. Biochem Biophys Res Commun, 2011, 408(1): 126-131

[43] YilgorP., TuzlakogluK., ReisR.L., et al.. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials, 2009, 30(21): 3551-3559